Compare Medtronic PLC (MDT) vs Wayfair Inc (W) Price & Performance

Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.

The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.

Wayfair (W) trades at $87.76, down 1.74% on the day, with a neutral technical signal and mixed earnings history. The company reported revenue of $12.46 billion in 2025 but a net loss of $313 million, reflecting a -2.41% net margin. Positive cash flow from operations of $534 million supports ongoing investments in logistics and new physical stores, as highlighted in recent Bloomberg coverage. Analyst consensus is a Moderate Buy with a $93.58 price target, suggesting modest upside from current levels.

The outlook balances growth initiatives like store expansion and AI integration against persistent profitability challenges. Key risks include high debt-to-asset ratio of 95.11% and competitive e-commerce pressures. Near-term catalyst is the Q2 2026 earnings report on August 4, 2026, where beating the $0.93 EPS expectation could drive momentum. Investors should weigh analyst optimism against fundamental headwinds in the housing market.